The Patent Finder

Mendus B.V.

8 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Dcprime B.V. (to 2023)

1
Ending by 2030
Apr 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 21, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,470,789Method for inducing and accelerating cells
In force
 · USPTO record
In forceUSPTO record
US 11,027,001Therapeutic cancer vaccines derived from a novel dendritic cell line
In force
 · USPTO record
In forceUSPTO record
US 10,064,923Therapeutic cancer vaccines derived from a novel dendritic cell line
In force
 · USPTO record
In forceUSPTO record
US 11,071,778Combination product for use in tumor vaccination
In force
 · USPTO record
In forceUSPTO record
US 11,052,144Methods of tumor vaccination
In force
 · USPTO record
In forceUSPTO record
US 12,091,681Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
In force
 · USPTO record
In forceUSPTO record
US 12,364,758Use of leukemia-derived cells in ovarian cancer vaccines
In force
 · USPTO record
In forceUSPTO record
US 12,397,055Methods of tumor vaccination
In force
 · USPTO record
In forceUSPTO record

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 1 abandoned · 1 no status recorded

Showing 1 to 4 of 4, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/804,310Ex Vivo Use of Modified Cells of Leukemic Origin for Enhancing the Efficacy of Adoptive Cell TherapyAug 14, 2024Pending
18/499,357Prognostic Biomarkers for Cancer Relapse Vaccination and the Use ThereofNov 1, 2023Abandoned
18/197,670Use of Leukemia-Derived Cells for Enhancing Natural Killer (NK) Cell TherapyMay 15, 2023Pending
18/119,487Mar 9, 2023No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited